Stockreport

Biomea Fusion, Inc. (BMEA) Discusses Top Line Results From COVALENT-112 Trial of Icovamenib in Type 1 Diabetes Transcript [Seeking Alpha]

Biomea Fusion, Inc.  (BMEA) 
PDF Company Participants Ramses Erdtmann - Co-Founder, President, COO & Director Michael J. Hitchcock - Interim CEO & Director Juan Frias Stephan Morris - Chief Dev [Read more]